OTC Markets OTCPK - Delayed Quote USD
Calidi Biotherapeutics, Inc. (CLDWW)
0.0055
-0.0010
(-15.38%)
At close: April 9 at 12:25:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
45
449
Cost of Revenue
--
--
--
14
94
Gross Profit
--
--
--
31
355
Operating Expense
21,595
21,595
26,107
23,159
10,837
Operating Income
-21,595
-21,595
-26,107
-23,128
-10,482
Net Non Operating Interest Income Expense
-933
-933
-3,749
-158
-614
Other Income Expense
333
333
656
-2,130
174
Pretax Income
-22,195
-22,195
-29,200
-25,416
-10,922
Tax Provision
14
14
16
11
11
Net Income Common Stockholders
-23,814
-23,814
-29,216
-25,427
-10,933
Diluted NI Available to Com Stockholders
-23,814
-23,814
-29,216
-25,427
-10,933
Total Operating Income as Reported
-21,776
-21,776
-28,992
-23,128
-10,482
Total Expenses
21,595
21,595
26,107
23,173
10,931
Net Income from Continuing & Discontinued Operation
-22,143
-22,143
-29,216
-25,427
-10,933
Normalized Income
-22,398.9600
-22,398.9600
-29,774.5300
-23,748.2500
-11,053.4500
Interest Expense
933
933
1,069
158
614
Net Interest Income
-933
-933
-3,749
-158
-614
EBIT
-21,262
-21,262
-28,131
-25,258
-10,308
EBITDA
-19,727
-19,727
-26,875
-25,005
-10,155
Reconciled Cost of Revenue
--
--
--
14
94
Reconciled Depreciation
1,535
1,535
1,256
253
153
Net Income from Continuing Operation Net Minority Interest
-22,143
-22,143
-29,216
-25,427
-10,933
Total Unusual Items Excluding Goodwill
324
324
707
-2,125
165
Total Unusual Items
324
324
707
-2,125
165
Normalized EBITDA
-20,051
-20,051
-27,582
-22,880
-10,320
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
68.0400
68.0400
148.4700
-446.2500
44.5500
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLMW Apollomics, Inc.
0.0078
-18.75%
RVMDW Revolution Medicines, Inc.
0.0870
+6.10%
CINGW Cingulate Inc.
0.0370
+11.78%
DNABW Ginkgo Bioworks Holdings, Inc.
0.0071
-4.05%
ZIVO ZIVO Bioscience, Inc.
16.00
+28.00%
SLN Silence Therapeutics plc
3.3200
+8.85%
AFMD Affimed N.V.
0.7703
+4.24%
VTYX Ventyx Biosciences, Inc.
1.1600
-1.69%
RVMD Revolution Medicines, Inc.
37.44
+1.57%
FGEN FibroGen, Inc.
0.3065
+2.30%